Hearing loss, tinnitus and vertigo among pediatric patients with COVID-19 infections: a review


  • Santosh Kumar Swain Department of Otorhinolaryngology and Head and Neck Surgery, IMS and SUM hospital, Siksha “O” Anusandhan University, K8, Kalinga Nagar,Bhubaneswar-751003, Odisha, India.




COVID-19, SARS-CoV-2, Hearing loss, Tinnitus, Vertigo, Pediatric patients


Coronavirus disease 2019(COVID-19) is a rapidly spreading contagious respiratory disease caused by the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) which manifests a plethora of health concerns. It may manifest with a wide range of clinical symptoms from no symptoms to respiratory failure and even multi-organ dysfunctions. The COVID-19 infection may present with otological manifestations such as hearing loss, tinnitus, vertigo, and otalgia. The otological manifestations may be due to the involvement of the eustachian tube and cochlea by COVID-19 infections. The damaging effect of the COVID-19 infection on the inner ear is a new finding which is yet to be explored. Pure tone audiometry and impedance audiometry are two important investigations for auditory assessment among pediatric patients with COVID-19 infection. Although hearing loss, tinnitus and vertigo are not common as fever and cough in COVID-19 patients, however, auditory-vestibular symptoms significantly affect the quality of life. Additionally, the anxiety associated with COVID-19 infections may attribute to aggravation of otoneurological symptoms like tinnitus. However, these otoneurological manifestations like hearing loss will affect the speech of the pediatric patients and result in morbid life in the current COVID-19 pandemic. Clinicians or pediatricians should be aware of the otoneurological manifestation in pediatric COVID-19 patients for early identification and management. This review article discusses the details of this epidemiology, etiopathology, assessment, and management of hearing loss, tinnitus, and vertigo among COVID-19 pediatric patients.


Swain SK, Behera IC, Ananda N. Pediatric tracheostomy in COVID-19 pandemic: a review. International Journal of Contemporary Pediatrics. 2021;8(3):602-8.

Nepal G, Rehrig JH, Shrestha GS, Shing YK, Yadav JK, Ojha R, et al. Neurological manifestations of COVID-19: a systematic review. Critical Care. 2020;24(1):1-11.

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-20.

Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: A literature review. J ClinNeurosci. 2020;77:8-12.

Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis.2020;94:55-8.

Ralli M, Stadio A, Greco A, Vincentiis M, Polimeni A. Defining the burden of olfactory dysfunction in COVID-19 patients. Eur Rev Med PharmacolSci. 2020; 24(7):3440-1.

National Institute for Health and Care Excellence (NICE). COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID19. Available online: https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-thelongtermeffects-of-covid19-pdf-66142028400325 (accessed on 28 April 2021)

Elibol E. Otolaryngological symptoms in COVID-19. European Archives of Oto-Rhino-Laryngology. 2021;278(4):1233-6.

Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, et al COVID‐19 diagnosis and management: a comprehensive review. Journal of internal medicine. 2020;288(2):192-206.

Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020;76:71–6.

Swain SK, Acharya S, Sahajan N. Otorhinolaryngological manifestations in COVID-19 infections: An early indicator for isolating the positive cases. Journal of the Scientific Society. 2020;47(2):63-8.

Swain SK, Agrawal R. Mastoid surgery: a high-risk aerosol generating surgical procedure in COVID-19 pandemic. Int J Otorhinolaryngol Head Neck Surg. 2020;6(10):1941-6.

Almufarrij I, Uus K, Munro KJ. Does coronavirus affect the audio-vestibular system? A rapid systematic review. Int. J. Audiol. 2020;59:487-91.

World Health Organisation fact sheet. Deaness and Hearing loss. In:World Health Fact Sheet ed. Geneva: World Health Organization; Feb. 2017. Available at www.who.int/mediacentre/ factsheets/fs300/en.

Wei M, Yuan J, Liu Y, Fu T, Yu X, Zhang ZJ. Novel coronavirus infection in hospitalized infants under 1 year of age in China. Jama. 2020;323(13):1313-4.

Saniasiaya J. Hearing Loss in SARS-CoV-2: What Do We Know? Ear Nose Throat J. 2021; 100:152-4.

Maharaj S, Alvarez MB, Mungul S, Hari K. Otologic dysfunction in patients with COVID-19: A systematic review. Laryngoscope. 2020;5:1192-6.

Swain SK, Das S, Lenka S. Sudden Sensorineural Hearing Loss among COVID-19 Patients-Our Experiences at an Indian Teaching Hospital. Siriraj Medical Journal. 2021;73(2):77-83.

Swain SK, Das S, Lenka S. Sudden Sensorineural Hearing Loss among COVID-19 Patients-Our Experiences at an Indian Teaching Hospital. Siriraj Medical Journal.2021;73(2):77-83.

Sriwijitalai W, Wiwanitkit V.Hearing loss and COVID-19: a note. Am J Otolaryngol. 2020;41(3):102473.

Chetty R, Batitang S, Nair R. Large artery vasculopathy in HIV-positive patients: another vasculitic enigma. Hum Pathol.2000;31(3):374-9.

Fraczek M, Resler K, Szetela B. Can we expect more patients with hearing loss due to COVID-19? The Hearing Journal. 2020;73(12):8-9.

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA neurology. 2020;77(6):683-90.

Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography fndings and other parameters of hemostasis. J ThrombHaemost. 2020;18(7):1738-42.

De Luca P, Scarpa A, De Bonis E, Cavaliere M, Viola P, Gioacchini MF, et al. Chloroquine and hydroxychloroquine ototoxicity; potential implications for SARS-CoV-2 treatment. A brief review of the literature. Am J Otol. 2020;8:102640.

Swain SK, Pani SR. Hearing loss: A neglected and morbid clinical entity in Corona Virus Disease 2019 pandemic. Amrita Journal of Medicine 2020;16(4):159-63.

Jafari Z, Kolb BE, Mohajerani MH. Hearing loss, tinnitus, and dizziness in COVID-19: a systematic review and meta-analysis. Canadian Journal of Neurological Sciences. 2021; 12:1-33.

Abramovich S, Prasher DK. Electrocochleography and brain-stem potentials in Ramsay Hunt Syndrome. Arch Otolaryngol Head Neck Surg. 1986;112(9):925-8.

Hong H, Wang Y, Chung HT, Chen CJ. Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children. Pediatr Neonatol. 2020;61(2):131-2.

Swain SK, Behera IC. Managing pediatric otorhinolaryngology patients in coronavirus disease-19 pandemic–A real challenge to the clinicians. Indian Journal of Child Health. 2020;7(9):357-62.

Swain SK. Smell and taste abnormalities: early clinical biomarkers for isolating the positive cases in COVID-19 pandemic. International Journal of Otorhinolaryngology and Head and Neck Surgery. 2021;7(1):196-201.

Viola P, Ralli M, Pisani D, Malanga D, Sculco D, Messina L, et al. Tinnitus and equilibrium disorders in COVID-19 patients: preliminary results. European Archives of Oto-Rhino-Laryngology. 2020: 1-6.

Hegemann SCA, Wenzel A. Diagnosis and treatment of vestibular neuritis/neuronitis or peripheral vestibulopathy (PVP)? Open questions and possible answers. Otol Neurotol. 2017;38:626–31.

Benghanem S, Mazeraud A, Azabou E, Chhor V, Shinotsuka CR, Claassen J, et al. Brainstem dysfunction in critically ill patients. Critical Care. 2020;24(1):1-4.

Cui C, Yao Q, Di Zhang YZ, Zhang K, Nisenbaum E, Cao P, et al. Approaching otolaryngology patients during the COVID-19 pandemic. Otolaryngol Head Neck Surg. 2020;1(2):234-7.

Swain SK, Pani SR. Incidence of Hearing Loss in COVID-19 Patients: A COVID Hospital-based Study in the Eastern Part of India. Int J Curr Res Rev. 2021;13:103-7.

Prayuenyong P, Kasbekar A, Baguley D. Clinical implications of chloroquine and hydroxychloroquine ototoxicity for COVID-19 treatment: a minireview. Front Public Heath.2020;8:252.

Swain SK, Sahu MC, Choudhury J. Sudden sensorineural hearing loss in children: Our experiences in tertiary care teaching hospital of eastern India. Pediatria Polska-Polish Journal of Paediatrics. 2018;93(2):127-31.

Swain SK, Das A, Sahu MC, Das R. Neonatal hearing screening: Our experiences at a tertiary care teaching hospital of eastern India. Pediatria Polska. 2017;92(6):711-5.

Swain SK, Jena PP. Clinical implications and future perspective of COVID-19 pandemic-a review. Int J Adv Med. 2021;8(2):334-40.

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269-71.

Hara JH, Zhang JA, Gandhi KR, Flaherty A, Barber W, Leung MA, et al. Oral and intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss. Laryngoscope Investig Otolaryngol. 2018;3:73-7.

Beukes EW, Onozuka J, Brazell TP, Manchaiah V. Coping with tinnitus during the COVID-19 pandemic. American Journal of Audiology. 2021;30:385-93.

Swain S, Behera I, Sahu M. Role of Ginkgo biloba for controlling residual dizziness after successful treatment of benign paroxysmal positional vertigo: Our experiences at a tertiary care teaching hospital of Eastern India. International Journal of Health & Allied Sciences. 2018;7(3):196-200.






Review Articles